Streptozotocin for Malignant Insulinomas and Carcinoid Tumor
Authors:
- Philip ScheinPSPhilip Schein
- Ronald KahnRKRonald Kahn
- Phillip GordenPGPhillip Gorden
- Samuel WellsSWSamuel Wells
- Vincent T. DeVitaVDVincent T. DeVita
- 1 October 1973
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 132 (4) , 555-561
Abstract
Research from JAMA Internal Medicine — Streptozotocin for Malignant Insulinomas and Carcinoid Tumor — Report of Eight Cases and Review of the LiteratureKeywords
This publication has 9 references indexed in Scilit:
- Proinsulin-like component of circulating insulin in the basal state and in patients and hamsters with islet cell tumorsJournal of Clinical Investigation, 1971
- Effects of Streptozotocin on Carbohydrate and Lipid Metabolism in the RatEndocrinology, 1971
- The Use of Insulin Dynamics in the Evaluation of Streptozotocin Therapy of Malignant Insulinomas1The Journal of Clinical Endocrinology & Metabolism, 1971
- Streptozotocin and Metastatic InsulinomaAnnals of Internal Medicine, 1971
- Metastatic Insulinoma Treated with StreptozotocinAnnals of Internal Medicine, 1971
- Effect of Streptozotocin on Qualitative Aspects of Plasma Insulin in a Patient with a Malignant Islet Cell TumorThe Journal of Clinical Endocrinology & Metabolism, 1970
- Effects of Streptozotocin in a Patient with Islet Cell CarcinomaDiabetes, 1969
- Spectrophotometric Determination of Streptozotocin.Analytical Chemistry, 1964
- Prediction of stability in pharmaceutical preparations VII. The solution degradation of the antibiotic streptozotocinJournal of the American Pharmaceutical Association (Scientific ed.), 1960